Publications by authors named "Siddharth Turkar"

Claim this Profile
P
Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes.
Rushabh Kothari, Vijay Patil, Ravi Krishna Madala, Ravikant Singh, Vikas T Talreja, Siddharth Turkar

Cancer Lett· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib: A novel and effective therapy for advanced liposarcoma.
Fen Saj, Deepak Dabkara, Siddharth Turkar, Bhawna Sirohi

Natl Med J India· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India.
Jyoti Bajpai, George Abraham, Avanish P Saklani, Anshul Agarwal, Sashanka Das, Siddharth Turkar

Front Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime?
Anita D'Souza, Dipalee Pawar, Anant Ramaswamy, Siddharth Turkar, Prabhat Bhargava

South Asian J Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A step ahead on CTHRC1, and not just reinventing the wheel!
Siddharth Turkar, Anant Ramaswamy, Vikas Ostwal

Chin Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Vijay Maruti Patil, Vanita Noronha, Amit Joshi, Jaiprakash Agarwal, Sarbani Ghosh-Laskar, Siddharth Turkar

Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised Patients.
Atul P Kulkarni, Manju Sengar, Girish Chinnaswamy, Ashit Hegde, Camilla Rodrigues, Siddharth Turkar

Indian J Crit Care Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach.
Vijay Patil, Vanita Noronha, Amit Joshi, Jayita Deodhar, Savita Goswami, Siddharth Turkar

J Glob Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients.
Vijay Patil, Amit Joshi, Vanita Noronha, Atanu Bhattacharjee, Sachin Dhumal, Siddharth Turkar

South Asian J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.
Amit Joshi, Vijay Patil, Vanita Noronha, Sachin Dhumal, Nikhil Pande, Siddharth Turkar

Oral Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expectations and preferences for palliative chemotherapy in head and neck cancers patients.
Vijay Patil, Amit Joshi, Vanita Noronha, Jayita Deodhar, Atanu Bhattacharjee, Siddharth Turkar

Oral Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis